U.S. Restricts Trade With Chinese Genomics Company

The U.S. has imposed trade restrictions on BGI, a significant Chinese genomics company, due to allegations that it's involved in forced labor and the mistreatment of minority groups. This move underscores growing concerns over human rights violations and the ethical implications of biotech research. As global biotech markets tighten their scrutiny, this action could set a precedent for how international trade and human rights intersect in the tech sector. For more details, check out the full article in The New York Times.